News
TEVA ▼ -0.4% - Teva Pharmaceutical Industries Limited
TEVA ▼ -0.4% - Teva Pharmaceutical Industries Limited
$TEVA - Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients
02-OCT-2026 08:00 AM ET
Share this post
More filings for $TEVA
TEVA ▲ +1.4% - Teva Pharmaceutical Industries LimitedOct 20, 2026TEVA ▲ +0.5% - Teva Pharmaceutical Industries LimitedOct 12, 2026TEVA ▲ +4.0% - Teva Pharmaceutical Industries LimitedOct 9, 2026TEVA ▲ +3.2% - Teva Pharmaceutical Industries LimitedOct 9, 2026TEVA ▼ -0.8% - Teva Pharmaceutical Industries LimitedSep 28, 2026TEVA ▼ -1.2% - Teva Pharmaceutical Industries LimitedSep 23, 2026
View full $TEVA filing history →💬 Comments
Loading comments…
Leave a comment